Molnos, Sophie
Wahl, Simone
Haid, Mark
Eekhoff, E. Marelise W.
Pool, René
Floegel, Anna
Deelen, Joris
Much, Daniela
Prehn, Cornelia
Breier, Michaela
Draisma, Harmen H.
van Leeuwen, Nienke
Simonis-Bik, Annemarie M. C.
Jonsson, Anna
Willemsen, Gonneke
Bernigau, Wolfgang
Wang-Sattler, Rui
Suhre, Karsten
Peters, Annette
Thorand, Barbara
Herder, Christian
Rathmann, Wolfgang
Roden, Michael
Gieger, Christian
Kramer, Mark H. H.
van Heemst, Diana
Pedersen, Helle K.
Gudmundsdottir, Valborg
Schulze, Matthias B.
Pischon, Tobias
de Geus, Eco J. C.
Boeing, Heiner
Boomsma, Dorret I.
Ziegler, Anette G.
Slagboom, P. Eline
Hummel, Sandra
Beekman, Marian
Grallert, Harald
Brunak, Søren
McCarthy, Mark I.
Gupta, Ramneek
Pearson, Ewan R.
Adamski, Jerzy
’t Hart, Leen M.
Funding for this research was provided by:
Helmholtz International Research Group (HRG-0018)
Helmholtz Initiative Personalized Medicine
Ministry of Innovation, Science, Research and Technology North Rhine-Westphalia
German Diabetes Association
German Federal Ministry of Health
Sixth Framework Programme (036894)
Innovative Medicines Initiative Joint Undertaking (115317)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (IGE01014/IGE05007)
Seventh Framework Programme (259679)
European Research Council (230374)
BBMRI-NL (184.021.007)
Biomedical Research program atWeill Cornell Medicine in Qatar
German Federal Ministry of Education and Research